The overall objective of Phase II in the supply chain design and facility location process includes all of the following except ______.
a. the regions where the facilities will be located
b. the availability of the necessary infrastructure
c. the role each facility would play in meeting the market requirements
d. the number of facilities needed for the supply chain
b. the availability of the necessary infrastructure
You might also like to view...
Answer the following statements true (T) or false (F)
1. Vacation pay is an example a liability that exists but the exact amount is not known. 2. Because a company usually does not know the amount of the year-end bonus at year-end, no liability is recorded. 3. Alpine Enterprises estimates that it will pay a 5% bonus on annual net income after deducting the bonus. The company reports net income of $500,000 before the calculation of the bonus. Employee Bonus Expense will be debited for $25,000. 4. Since a company usually does not know the amount of the year-end bonus at year-end, the company estimates the amount of the bonus based on a percentage. 5. Jamison Enterprises estimates that it will pay a 5% bonus on annual net income after deducting the bonus. If Jamison reports net income of $480,000 before the calculation of the bonus, the amount of the bonus is $24,000.
Ahmed & Co. makes and sells two types of shoes, Plain and Fancy. Data concerning these products are as follows: Plain FancyUnit selling price$20.00 $35.00 Variable cost per unit 12.00 24.50 Sixty percent of the unit sales are Plain, and annual fixed expenses are $45,000. Assuming that the sales mix remains constant, the number of units of Fancy that Ahmed must sell to break even is:
A. 3,375. B. 3,000. C. 5,000. D. 2,000. E. 5,625.
In a normal distribution, it is known that 27.34% of all the items are included from 100 up to the mean, and another 45.99% of all the items are included from the mean up to 145. Determine the mean and the standard deviation of the distribution.
What will be an ideal response?
What should AstraZeneca do differently with respect to managing their expatriates? And why?
What will be an ideal response?